Cancer cells are remarkably good at adapting to stress. When treatments damage them, they often find new ways to survive, ...

GLP-1 drugs may be linked to a lower risk of cancer progression, according to new research that will be presented next week at the American Society of Clinical Oncology’s annual meeting.

The study, published today in Cancer Cell, generated spatial transcriptomic maps in precancerous and more advanced stages of lung cancer to provide a deeper understanding of early lung cancer ...

Metastatic progression reduction is associated with GLP-1 RA initiation after cancer diagnosis across multiple solid tumors.

Ovarian cancer is a common gynaecologic cancer in women It is often diagnosed late putting the lives of women at risk ...

Clinical trials at Emory and Piedmont are signaling a potential breakthrough in treating pancreatic cancer, one of the nation ...

A Phase III clinical trial led by Neeraj Agarwal, MD, FASCO, senior director of clinical research at Huntsman Cancer ...

By Sneha S K May 31 (Reuters) - Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six ...